C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Invests $597,000 in DaVita Inc. (NYSE:DVA)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new position in shares of DaVita Inc. (NYSE:DVA - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 3,994 shares of the company's stock, valued at approximately $597,000.

Several other institutional investors have also modified their holdings of the stock. Venturi Wealth Management LLC raised its holdings in DaVita by 59.8% in the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock valued at $61,000 after buying an additional 152 shares during the period. CIBC Asset Management Inc raised its holdings in DaVita by 1.4% in the 4th quarter. CIBC Asset Management Inc now owns 7,730 shares of the company's stock valued at $1,156,000 after buying an additional 109 shares during the period. Sanctuary Advisors LLC purchased a new stake in DaVita in the 4th quarter valued at about $180,000. Strategic Financial Concepts LLC purchased a new stake in DaVita in the 4th quarter valued at about $9,371,000. Finally, Summit Trail Advisors LLC raised its holdings in DaVita by 9.0% in the 4th quarter. Summit Trail Advisors LLC now owns 25,416 shares of the company's stock valued at $3,801,000 after buying an additional 2,107 shares during the period. Hedge funds and other institutional investors own 90.12% of the company's stock.

DaVita Trading Down 2.5 %

NYSE:DVA traded down $3.59 on Friday, reaching $142.33. 1,605,084 shares of the company's stock were exchanged, compared to its average volume of 983,216. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The firm has a market capitalization of $11.39 billion, a price-to-earnings ratio of 13.25, a price-to-earnings-growth ratio of 1.07 and a beta of 0.94. The business has a fifty day moving average of $161.03 and a 200-day moving average of $157.86. DaVita Inc. has a 52-week low of $120.78 and a 52-week high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, analysts expect that DaVita Inc. will post 10.76 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, Barclays boosted their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a report on Tuesday. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $162.80.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.